Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Johannes Czernin
University of California Los Angeles, Department: None
Should you be removed from our database? Contact us at [email protected]. Read more below.
Sofie Biosciences
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Professor Czernin provides aids JCCC clinical investigators who wish to incorporate molecular imaging in their clinical studies. He will work closely with the PI and Director in the planning and developing interdisciplinary and translational conferences. They will meet regularly to assess program area activities, prepare annual reports and presentations and identify new areas for development. He is a founder of the company.
Please note the original FCOI for this report is 4339. Although the FCOI had not been reported timely due to confusion with the reporting requirements for renewals awards, the FCOI has been managed since the start of the type 2 award.
Cancer Center Support Grant
RELEVANCE (See instructions): UCLA's Jonsson Comprehensive Cancer Center was first designated by the National Cancer Institute in 1976. It was among the first centers in the country to receive this prestigious designation. Since that time, the JCCC has continued to build on its successes to become one of the premier centers in the United States. With more than 240 members and $160M in cancer-related research funding, its successes continue to expand and its potential for further growth promising.
Filed on April 14, 2015.
Tell us what you know about Johannes Czernin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Johannes Czernin”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Johannes Czernin | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | $200,000 - $249,999 |
| Johannes Czernin | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | Value cannot be readily determined |
| Johannes Czernin | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | Value cannot be readily determined |
| Johannes Czernin | University of California Los Angeles | Conflict of Interest | Sofie Biosciences | $150,000 - $199,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.